We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.1B
AUM Growth
+$269M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
9.04%
Holding
817
New
56
Increased
354
Reduced
285
Closed
43

Top Buys

Rank Stock Value
1
EXPO icon
Exponent
EXPO
+$35M
2
MMS icon
Maximus
MMS
+$21.2M
3
JBTM
JBT Marel
JBTM
+$18.4M
4
RLI icon
RLI Corp
RLI
+$16.7M
5
BBSI icon
Barrett Business Services
BBSI
+$16.6M

Top Sells

Rank Stock Value
1
FORM icon
FormFactor
FORM
+$60.8M
2
MKSI icon
MKS Inc
MKSI
+$48.2M
3
AAOI icon
Applied Optoelectronics
AAOI
+$35.3M
4
FTAI icon
FTAI Aviation
FTAI
+$30.6M
5
SII
Sprott
SII
+$28.9M

Sector Composition

Rank Sector Weight
1 Industrials 26.3%
2 Technology 18.47%
3 Financials 15.89%
4 Consumer Discretionary 13.13%
5 Healthcare 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IIIN icon
401
Insteel Industries
IIIN
$593M
$7.44M 0.07%
221,388
+15,000
+7% +$514K
ODC icon
402
Oil-Dri
ODC
$1.33B
$7.38M 0.07%
113,314
– –
NOG icon
403
Northern Oil and Gas
NOG
$2.78B
$7.36M 0.07%
251,891
+32,000
+15% +$828K
SONO icon
404
Sonos
SONO
$1.79B
$7.36M 0.07%
549,212
+76,946
+16% +$1.16M
ESPR
405
DELISTED
Esperion Therapeutics
ESPR
$7.2M 0.07%
2,626,995
-974,528
-27% -$3.09M
AVNS
406
DELISTED
Avanos Medical
AVNS
$7.2M 0.07%
513,703
+453,000
+746% +$6.1M
CTKB icon
407
Cytek Biosciences
CTKB
$601M
$7.18M 0.07%
1,642,368
-50,289
-3% -$237K
SPIR icon
408
Spire Global
SPIR
$569M
$7.17M 0.07%
+570,000
New +$6.09M
PROF
409
Profound Medical
PROF
$254M
$7.14M 0.07%
1,116,348
+126,000
+13% +$870K
CVCO icon
410
Cavco Industries
CVCO
$4.39B
$7.12M 0.07%
14,700
-7,804
-35% -$4.43M
IDT icon
411
IDT Corp
IDT
$1.71B
$7.1M 0.07%
144,628
-27,739
-16% -$1.37M
IWN icon
412
iShares Russell 2000 Value ETF
IWN
$14.7B
$7.1M 0.07%
37,426
+15,764
+73% +$3.05M
HBT icon
413
HBT Financial
HBT
$1.3B
$7.07M 0.07%
264,422
-6,515
-2% -$177K
FTDR icon
414
Frontdoor
FTDR
$5.71B
$6.98M 0.07%
132,052
+18,384
+16% +$1.1M
CERT icon
415
Certara
CERT
$1.28B
$6.93M 0.07%
+1,215,051
New +$9.27M
CLFD icon
416
Clearfield
CLFD
$407M
$6.8M 0.07%
256,990
-122,922
-32% -$3.75M
RXO icon
417
RXO
RXO
$3.68B
$6.77M 0.07%
463,000
+193,000
+71% +$2.83M
LEGH icon
418
Legacy Housing
LEGH
$675M
$6.71M 0.07%
328,300
+10,000
+3% +$208K
UNTY icon
419
Unity Bancorp
UNTY
$585M
$6.66M 0.07%
128,428
-946
-0.7% -$49.8K
TFX icon
420
Teleflex
TFX
$5.84B
$6.64M 0.07%
55,530
-36,500
-40% -$4.02M
ACU icon
421
Acme United Corp
ACU
$240M
$6.57M 0.06%
146,403
-1,000
-0.7% -$43.5K
ASA
422
ASA Gold and Precious Metals
ASA
$1.23B
$6.57M 0.06%
105,887
-31,000
-23% -$2.09M
SHEL icon
423
Shell
SHEL
$250B
$6.51M 0.06%
70,000
– –
CCNE icon
424
CNB Financial Corp
CCNE
$1.01B
$6.48M 0.06%
223,731
-38,449
-15% -$1.07M
ADEA icon
425
Adeia
ADEA
$2.89B
$6.4M 0.06%
266,269
-141,565
-35% -$2.87M
15 16
17
18 19

Similar funds

JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
LC
Loews Corp New York $12.5B AUM 4.69% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $12.6B AUM 11.86% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Royce & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Royce & Associates held 817 positions worth $10.1B, up 2.7% from $9.86B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Royce & Associates's Q1 2026 filing shows 56 new, 354 increased, 285 reduced and 43 closed positions. Its largest new stake was Azenta: 523,308 shares worth $11.1M. The largest sale was FormFactor, an estimated $60.8M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q1 2026 buy was Azenta: 523,308 shares worth $11.1M.
  • Royce & Associates added most to Exponent in Q1 2026, an estimated $35M increase.
  • Royce & Associates's biggest Q1 2026 reduction was FormFactor, cutting an estimated $60.8M.
  • Royce & Associates fully exited TEGNA Inc in Q1 2026, selling an estimated $27.8M.
  • Royce & Associates's ten largest holdings make up 9% of its $10.1B portfolio in Q1 2026.
  • Royce & Associates opened 56 new positions and closed 43 in Q1 2026.
  • Royce & Associates's portfolio value rose 2.7% quarter-over-quarter to $10.1B.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.